Funded Tech Companies

Affini-T Therapeutics

Headquartered in St. Watertown, Affini-T Therapeutics has funding from ARM, Alexandria Venture Investments and Catalio Capital Management.

Company Overview

Contact Information

Company Background Information

Overview

Developer of therapeutics platform intended to target oncogenic driver mutations. The company specializes in providing immune cell technology which unlocks the power of T cells that leverages synthetic biology and gene editing technologies to outsmart the immunosuppressive tumor microenvironment and generate a sustained anti-tumoral response, enabling doctors to deliver transformative therapies intended to cure patients.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/22/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jak Knowles

        

Chief Operating Officer

Kathy Yi

        

Chief Scientific Officer

Loïc Vincent

        

Chief Technical Officer

Kim Nguye

        

Company Investors

• ARM
• Alexandria Venture Investments
• Catalio Capital Management
• Agent Capital
• Parker Institute for Cancer Immunotherapy
• Humboldt Fund
• Vida Ventures
• Erasca Ventures

Browse more funded tech companies:

Affineti Biologics | Affinia Therapeutics

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary